Mumbai-based pharmaceutical giant Cipla will distribute and market the drug in India. Show Full Article Inhaled from the mouth at the beginning of a meal, Afrezza dissolves rapidly into the lungs and ...

Sensex and Nifty closed flat in cautious trade on Wednesday. In today's session, several stocks such as Reliance Power Ltd, Cipla, PC Jeweller, etc are likely to be in focus due to recent developments ...

Cipla's stock is priced at Rs 1453.35, reflecting a minor decrease of 0.13% today. Over the past five years, the company has achieved returns of 223.52%. Cipla's current price is Rs 1454.95, ...

Drugmaker Cipla has got regulatory approval to market Afrezza, a rapid acting insulin delivered through an inhaler, as compared to other insulins given through injections. The Central Drugs ...

Credit: Jan Thijs From 2011 to 2012, thieves stole $18 million worth of maple syrup from the Federation of Quebec Maple Syrup Producers. Among the most valuable heists in Canadian history (and ...

Cipla's Ltd. stock saw a decline on Monday after a large block of shares changed hands in pre-market trading. A total of 1.39 crore shares, representing 1.72% of the company’s equity, were traded at ...

A total of 1.39 crore shares of Cipla Ltd, representing 1.72 percent of the company’s equity, were sold through block deals on Monday. Promoters are the likely sellers, as reported previously by ...

Hindustan Unilever (HUL): HUL in its investor presentation said that 10 brands are at the sweet spot of premiumisation. The maker of Lux soaps pointed out in its presentation that its six long-term ...

A collection of the most-viewed Moneycontrol videos.

As many as 1.39 crore shares or 1.72% equity of Cipla Ltd changed hands in four block deals on Monday, December 2. Prompters Samina Hamied and Runiana Hamied offloaded 1.72% stake of the company ...